A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF HYPERLIPIDEMIA, PROCESSES FOR PRODUCING THE SAME AND THE USE THEREOF
    3.
    发明公开
    A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF HYPERLIPIDEMIA, PROCESSES FOR PRODUCING THE SAME AND THE USE THEREOF 有权
    药物组合物治疗和/或高脂血症防治方案; 方法用于生产和使用

    公开(公告)号:EP1829519A1

    公开(公告)日:2007-09-05

    申请号:EP05817628.0

    申请日:2005-12-05

    IPC分类号: A61K6/00

    摘要: The present invention discloses a pharmaceutical composition comprising Polygonum multiflorum Thunb, which comprises Polygonum multiflorum Thunb, Fructus Crataegi, Salvia miltiorrhiza Bunge and Radix Notoginseng. If needed, the pharmaceutical composition may comprise the pharmaceutically acceptable carriers. The weight ratio of Polygonum multiflorum Thunb, Salvia miltiorrhiza Bunge, Fructus Crataegi and Radix Notoginseng in the present composition is as follows: 10 to 20 parts of Polygonum multiflorum Thunb, 5 to 15 parts of Salvia miltiorrhiza Bunge, 10 to 20 parts of Fructus Crataegi and 1 to 10 parts of Radix Notoginseng. Also, the present invention discloses the methods for preparing the composition, including directly pulverizing the medicines into powder to produce the composition or preparing the medicines into the extracts and then make the extracts into drugs. The composition of the present invention has an effect of lowering blood lipid, and therefore can be used in preparation of drugs for treatment and/or prevention of hyperlipidemia. The present invention also discloses a method to treat and/or prevent hyperlipidemia.

    摘要翻译: 本发明盘松动的药物组合物,包含何首乌,其包括何首乌,山楂,丹参和三七。 如果需要,所述药物组合物可包含药学上可接受的载体。 何首乌,丹参,山楂和三七的本发明组合物的重量比为如下:10至20份何首乌,5至15份丹参,10至20份山楂的 和1至10份三七的。 所以,本发明盘松散组合物的制备,包括直接粉碎药物成粉末,以产生所述组合物或制备的药剂进入提取物,然后使提取物到药物的方法。 本发明的组合物具有以实现降低血脂的,并且因此可以在制备的药物用于治疗和/或预防高脂血症中使用。 因此,本发明光盘松的方法治疗和/或预防高脂血症。

    PREPARATION AND APPLICATION OF TRANSHINTOTALPHENOLIC ACID
    7.
    发明公开
    PREPARATION AND APPLICATION OF TRANSHINTOTALPHENOLIC ACID 有权
    VERFAHREN ZUR HERSTELLUNG VON GESAMT-SALVIANOLSÄURE

    公开(公告)号:EP1506951A1

    公开(公告)日:2005-02-16

    申请号:EP03732181.7

    申请日:2003-05-21

    摘要: A process for preparing tanshintotalphenolic acid and the use of the product are disclosed. The process comprises: tanshin is hot-extracted with water, the extract is separated and refined by polyamide column and macroporous adsorption resin column, and lyophilized to obtain tanshintotalphenolic acid. The yield of the final end product is more than 4 percent based on the amount of crude drug and the content of totalphenolic acid is more than 80 percent. The tanshintotalphenolic acid obtained can be used as the medicine for preventing and treating cerebrovascular and cardiovascular diseases and so on.

    摘要翻译: 公开了制备丹参酚酸的方法及其用途。 该方法包括:将丹参用水热萃取,聚酰胺柱和大孔吸附树脂柱分离精制提取物,冻干得到丹参酚酸。 最终产品的产率基于生药量大于4%,总酚酸含量大于80%。 获得的丹参酚酸可用作预防和治疗脑血管和心血管疾病的药物等。

    METHOD FOR THE PREPARATION OF TOTAL SALVIANOLIC ACID
    9.
    发明授权
    METHOD FOR THE PREPARATION OF TOTAL SALVIANOLIC ACID 有权
    制备总丹酚酸的方法

    公开(公告)号:EP1506951B9

    公开(公告)日:2009-08-26

    申请号:EP03732181.7

    申请日:2003-05-21

    摘要: A process for preparing tanshintotalphenolic acid and the use of the product are disclosed. The process comprises: tanshin is hot-extracted with water, the extract is separated and refined by polyamide column and macroporous adsorption resin column, and lyophilized to obtain tanshintotalphenolic acid. The yield of the final end product is more than 4 percent based on the amount of crude drug and the content of totalphenolic acid is more than 80 percent. The tanshintotalphenolic acid obtained can be used as the medicine for preventing and treating cerebrovascular and cardiovascular diseases and so on.

    摘要翻译: 公开了制备丹参全草酚酸的方法和产品的用途。 该工艺包括:将丹参用水进行热萃取,萃取液经聚酰胺柱和大孔吸附树脂柱分离精制,冷冻干燥得到丹参全草酚酸。 基于生药量,最终成品的收率大于4%,总酚酸含量大于80%。 得到的丹参总酚酸可以作为预防和治疗脑血管疾病和心血管疾病的药物等。